These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30173895)

  • 1. [Is the collecting activity of regional pharmacovigilance centers influenced by regional demographic or health determinants?].
    Lam L; Desitter C; Maison P
    Therapie; 2019 Jun; 74(3):333-341. PubMed ID: 30173895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient involvement in pharmacovigilance: determinants and evolution of reporting from 2011 to 2020 in France.
    Adopo D; Daynes P; Benkebil M; Debs A; Jonville-Berra AP; Polard E; Micallef J; Maison P
    Eur J Clin Pharmacol; 2023 Feb; 79(2):229-236. PubMed ID: 36508012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The congress of the French Society of Pharmacology and Therapeutics celebrate in Nancy, 20 April 2016, 40 years of French Regional Pharmacovigilance Centres!].
    Jonville-Béra AP; Mallaret M; Sgro C;
    Therapie; 2016 Sep; 71(4):351-4. PubMed ID: 27296805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacovigilance center --internal medicine interactions: A useful diagnostic tool].
    Rochoy M; Gautier S; Bordet R; Caron J; Launay D; Hachulla E; Hatron PY; Lambert M
    Rev Med Interne; 2015 Aug; 36(8):516-21. PubMed ID: 25771174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).
    Thiessard F; Roux E; Miremont-Salamé G; Fourrier-Réglat A; Haramburu F; Tubert-Bitter P; Bégaud B
    Drug Saf; 2005; 28(8):731-40. PubMed ID: 16048358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical pharmacy and pharmacovigilance over a period of nine years in hospital].
    Guédat MG; Gouraud A; Ramiah T; Demazière J; Delanoy B; Vial T; Leboucher G; Charpiat B
    Therapie; 2012; 67(3):243-50. PubMed ID: 22874491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Satisfaction of a pharmacovigilance declaration support network in general practice].
    Driot D; Figuet L; Birebent J; Coste S; Durrieu G; Jacquot J; Bismuth M
    Therapie; 2018 Dec; 73(6):483-493. PubMed ID: 29921459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the website of the Nord-Pas-de-Calais regional pharmacovigilance center].
    Rochoy M; Béné J; Messaadi N; Auffret M; Gautier S
    Therapie; 2016 Jun; 71(3):329-33. PubMed ID: 27235657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse drug reactions in pediatrics: Experience of a regional pharmacovigilance center].
    Saint-Martin C; Kanagaratnam L; de Boissieu P; Azzouz B; Abou Taam M; Trenque T
    Therapie; 2016 Oct; 71(5):467-473. PubMed ID: 27203165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
    Auffret M; Labreuche J; Duhamel A; Deheul S; Cottencin O; Bordet R; Gautier S; Rolland B
    Drug Saf; 2017 Mar; 40(3):257-262. PubMed ID: 27988884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
    Hajj A; Hallit S; Ramia E; Salameh P;
    Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [French pharmacovigilance database system: examples of utilisation].
    Moore N; Noblet C; Kreft-Jais C; Lagier G; Ollagnier M; Imbs JL
    Therapie; 1995; 50(6):557-62. PubMed ID: 8745956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serious adverse drug reactions with tramadol reported to the French pharmacovigilance database between 2011 and 2015].
    Moulis F; Rousseau V; Abadie D; Masmoudi K; Micallef J; Vigier C; Pierre S; Dautriche A; Montastruc F; Montastruc JL
    Therapie; 2017 Dec; 72(6):615-624. PubMed ID: 28755832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa.
    Terblanche A; Meyer JC; Godman B; Summers RS
    Hosp Pract (1995); 2018 Oct; 46(4):221-228. PubMed ID: 30092683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: a win-win bet with Health Authorities!].
    Jonville-Bera AP; Gautier S; Micallef J; Massy N; Atzenhoffer M; Drici MD; Grandvuillemin A;
    Therapie; 2023; 78(5):477-488. PubMed ID: 36890032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.
    Durrieu G; Jacquot J; Mège M; Bondon-Guitton E; Rousseau V; Montastruc F; Montastruc JL
    Drug Saf; 2016 Dec; 39(12):1189-1195. PubMed ID: 27688025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-marketing drug withdrawals: Pharmacovigilance success, regulatory problems.
    Aronson JK
    Therapie; 2017 Oct; 72(5):555-561. PubMed ID: 28461037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an educational intervention on knowledge and attitude regarding pharmacovigilance and consumer pharmacovigilance among community pharmacists in Lalitpur district, Nepal.
    Jha N; Rathore DS; Shankar PR; Bhandary S; Pandit RB; Gyawali S; Alshakka M
    BMC Res Notes; 2017 Jan; 10(1):4. PubMed ID: 28057047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug's safety profile.
    Motola D; Melis M; Lo Bianco S; Buccellato E; Biagi C; Vaccheri A
    Expert Opin Drug Saf; 2014 Jul; 13(7):867-73. PubMed ID: 24809453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.